The document discusses the significance of wearable technology in the pharmaceutical industry, highlighting how aggregated data from devices can enhance patient care and lifestyle choices. Experts from CMI/Compas explore potential partnerships between pharma and tech companies, the evolving consumer landscape towards wearable devices, and the necessity for these devices to blend technology with fashion to gain wider acceptance. The industry's forecast suggests significant growth, with projections for the wearable market reaching $30 to $50 billion in the coming years.